Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoichi Imamura

Showing results (181-190 of 206) with videos related to

Pageof 21
Sort By:
Biochemical and Biophysical Research Communications|January 17, 2020
The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancerYu Ishizuya, Motohide Uemura, Ryohei Narumi, et al.
Cancer Science|January 25, 2020
MicroRNA-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinomaCong Wang, Motohide Uemura, Eisuke Tomiyama, et al.
International Journal of Clinical Oncology|January 20, 2021
The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective studyTaigo Kato, Akira Nagahara, Norihiko Kawamura, et al.
International Journal of Clinical Oncology|February 14, 2025
Characteristics of patients with metastatic renal cell carcinoma who do not respond to axitinib treatmentKojiro Ohba, Takahiro Osawa, Takahiro Kojima, et al.
Anticancer Research|November 4, 2021
Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell CarcinomaTaigo Kato, Akira Nagahara, Norihiko Kawamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 28, 2022
Diagnostic and prognostic significance of tartrate-resistant acid phosphatase type 5b in newly diagnosed prostate cancer with bone metastasis: A real-world multi-institutional studyGaku Yamamichi, Taigo Kato, Satoru Yumiba, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 29, 2022
A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in JapanTaigo Kato, Satoru Yumiba, Wataru Nakata, et al.
Cancer Science|October 7, 2017
Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinomaToshiro Kinouchi, Motohide Uemura, Cong Wang, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 9, 2024
Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of JapanShotaro Nakanishi, Yumi Fukushima, Junichi Inokuchi, et al.
Frontiers in Oncology|June 9, 2020
Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder CancerYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Pageof 21

Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Biochemical and Biophysical Research Communications|January 17, 2020
The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancerYu Ishizuya, Motohide Uemura, Ryohei Narumi, et al.
Cancer Science|January 25, 2020
MicroRNA-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinomaCong Wang, Motohide Uemura, Eisuke Tomiyama, et al.
International Journal of Clinical Oncology|January 20, 2021
The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective studyTaigo Kato, Akira Nagahara, Norihiko Kawamura, et al.
International Journal of Clinical Oncology|February 14, 2025
Characteristics of patients with metastatic renal cell carcinoma who do not respond to axitinib treatmentKojiro Ohba, Takahiro Osawa, Takahiro Kojima, et al.
Anticancer Research|November 4, 2021
Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell CarcinomaTaigo Kato, Akira Nagahara, Norihiko Kawamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 28, 2022
Diagnostic and prognostic significance of tartrate-resistant acid phosphatase type 5b in newly diagnosed prostate cancer with bone metastasis: A real-world multi-institutional studyGaku Yamamichi, Taigo Kato, Satoru Yumiba, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 29, 2022
A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in JapanTaigo Kato, Satoru Yumiba, Wataru Nakata, et al.
Cancer Science|October 7, 2017
Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinomaToshiro Kinouchi, Motohide Uemura, Cong Wang, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 9, 2024
Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of JapanShotaro Nakanishi, Yumi Fukushima, Junichi Inokuchi, et al.
Frontiers in Oncology|June 9, 2020
Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder CancerYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Pageof 21